New Zealand Psychologist Assembles First Study Microdosing Cancer Patients with LSD
University of Auckland researcher hopes the psychedelic treatment will enhance the effect of psychotherapy, easing end-of-life distress in patients.
Entries by Jennifer Walker-Journey
Want to Try Psychedelics in a Clinical Setting? 56 Trials Now Recruiting Volunteers
Here’s how to become a research subject for psilocybin, LSD, MDMA, ibogaine, and 5-MeO-DMT studies.
Psychedelic Business Spotlight: July 9, 2021
This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.
Another California City Proposes Decriminalizing Psychedelics
Decriminalization is one step behind legalization. Selling entheogenic plants or fungi remains a felony that could warrant prison time.
Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression Treatment
Cybin CEO says agreement “serves as a major step toward establishing a national distribution network for future psychedelic therapies.”
Single Dose of Psilocybin Strengthens Brain Connections in Mice, According to Yale Study
“It was a real surprise to see such enduring changes from just one dose of psilocybin,” says senior study author Alex Kwan.
The Spiritual Reason Michael Pollan Explores Mescaline in New Book ‘This Is Your Mind on Plants’
The author’s latest deep dive into plants’ effect on consciousness also investigates caffeine and opium.
Can Psychedelics Reduce Domestic Violence? New Study Suggests Yes
Alcohol, methamphetamine and cocaine have been linked to increased aggression in men, but psychedelics appear to have opposite effect.
Psychedelic Business Spotlight: July 2, 2021
This week in psychedelic business news: Companies embrace the psychedelic aspects of VR, Braxia trains therapists in psychedelic best practices, and Allied gears up to provide its psychedelic formulation to PTSD patients.
Harvard Law Launches Psychedelics Regulation Research Project
POPLAR is the first academic initiative focused on psychedelics law and policy.
